Search Results - "DE BOER, Hans D"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    ClC-1 Inhibition as a Mechanism for Accelerating Skeletal Muscle Recovery After Neuromuscular Block in Rats by Skals, Marianne, Broch-Lips, Martin, Skov, Martin Brandhøj, Riisager, Anders, Ceelen, Judith, Nielsen, Ole Bækgaard, Brull, Sorin J., de Boer, Hans D., Pedersen, Thomas Holm

    Published in Nature communications (28-10-2024)
    “…Neuromuscular blocking agents are used commonly to induce skeletal muscle relaxation during surgery. While muscle relaxation facilitates surgical procedures…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Rocuronium and sugammadex in a 3 days old neonate for draining an ovarian cyst. Neuromuscular management and review of the literature by Carlos, Ricardo Vieira, Torres, Marcelo Luis Abramides, de Boer, Hans D.

    “…A case is reported in which a 3-days old neonate with a giant ovarian cyst was scheduled for surgery. The patient received a dose of sugammadex to reverse a…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Is lower-dose sugammadex a cost-saving strategy for reversal of deep neuromuscular block? Facts and fiction by de Boer, Hans D, Carlos, Ricardo V, Brull, Sorin J

    Published in BMC anesthesiology (06-11-2018)
    “…Sugammadex, a γ-cyclodextrin derivative, belongs to a new class of selective relaxant binding agents. Sugammadex was approved 10-years ago by the European…”
    Get full text
    Journal Article
  11. 11

    Developing expert international consensus statements for opioid-sparing analgesia using the Delphi method by Sng, Daniel Da Der, Uitenbosch, Giulia, de Boer, Hans D, Carvalho, Hugo Nogueira, Cata, Juan P, Erdoes, Gabor, Heytens, Luc, Lois, Fernande Jane, Pelosi, Paolo, Rousseau, Anne-Françoise, Forget, Patrice, Nesvadba, David

    Published in BMC anesthesiology (27-02-2023)
    “…The management of postoperative pain in anaesthesia is evolving with a deeper understanding of associating multiple modalities and analgesic medications…”
    Get full text
    Journal Article Web Resource
  12. 12
  13. 13

    Risks and benefits of the skin-to-skin cesarean section - a retrospective cohort study by Posthuma, Selina, Korteweg, Fleurisca J., van der Ploeg, J. Marinus, de Boer, Hans D., Buiter, Hannah D., van der Ham, David P.

    “…Objective: Comparing maternal and neonatal outcomes after conventional cesarean section (CS) versus a "natural" or "skin-to-skin" cesarean section (SSCS)…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Reversal of rocuronium-induced neuromuscular block by sugammadex is independent of renal perfusion in anesthetized cats by Staals, Lonneke M., de Boer, Hans D., van Egmond, Jan, Hope, Frank, van de Pol, Francien, Bom, Anton H., Driessen, Jacques J., Booij, Leo H. D. J.

    Published in Journal of anesthesia (01-04-2011)
    “…Purpose Sugammadex is a selective relaxant binding agent designed to encapsulate the aminosteroidal neuromuscular blocking agent rocuronium, thereby reversing…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Opportunities and Challenges for the Next Phase of Enhanced Recovery After Surgery: A Review by Ljungqvist, Olle, de Boer, Hans D, Balfour, Angie, Fawcett, William J, Lobo, Dileep N, Nelson, Gregg, Scott, Michael J, Wainwright, Thomas W, Demartines, Nicolas

    Published in JAMA surgery (01-08-2021)
    “…Enhanced Recovery After Surgery (ERAS) is a global surgical quality improvement initiative now firmly entrenched within the field of perioperative care…”
    Get more information
    Journal Article
  18. 18

    Neuromuscular transmission: New concepts and agents by de Boer, Hans D., PhD

    Published in Journal of critical care (01-03-2009)
    “…Abstract Sugammadex is the first selective relaxant binding agent which was originally designed to reverse the steroidal NMB drug rocuronium. The results of…”
    Get full text
    Journal Article
  19. 19
  20. 20